Clinical trial
Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response
NCT03609099 is registered in ClinicalTrials.gov with David Garcia Cinca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response
- Lead sponsor
- David Garcia Cinca
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 15, 2019
- Completion date
- May 15, 2021
- Enrollment
- 424 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.